Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters
Document Type
Year range
1.
Clinical study of antibody cocktail therapy for COVID-19
Yamada, K.; Suzuki, S.; Tanino, Y.; Suzuki, K.; Ichikawa, T.; Nakajima, M.; Tampo, A.; Kukita, S.; Kuroda, S.; Uehara, A.; Sakagami, H.; Nagashima, Y.; Nakamura, A.; Takahashi, K.; Saito, S.; Sato, R.; Kakinoki, Y..
Journal of the Japanese Association for Infectious Diseases ; 96(5):179-185, 2022.
Article in Japanese | GIM | ID: covidwho-2203546

ABSTRACT

Background: Randomized phase III clinical trials suggest that the antibody cocktail containing casirivimab and imdevimab reduces the risk of hospitalization/death in high-risk COVID-19 patients. However, the efficacy of the cocktail in daily clinical practice remains unknown.

2.
Maintaining inclusive pedagogy in online ELT classrooms during and beyond the COVID-19 pandemic in Japan
Lawrence, L.; Nagashima, Y..
The Routledge Handbook of Media Education Futures Post-Pandemic ; : 28-36, 2022.
Article in English | Scopus | ID: covidwho-2055895
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL